RAC 0.60% $1.69 race oncology ltd

Would first get some data from dose-escalation stage. So depends...

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29637
    Would first get some data from dose-escalation stage. So depends how long it takes to recruit each dose cohort and advance to next.

    Next to consider is time to evaluate response.

    https://breastcancernow.org/informa...cancer-treatment/chemotherapy/ac-chemotherapy

    5ED63BBD-3AF2-49E7-A177-55580569E18F.jpeg

    Response I think would be measured after a full set of cycles. Would be fairly onerous to subject a patient to a CT scan every 3 weeks and accessing machines at this high rate would be challenging. So they might evaluate at 3-4 month intervals ( as above ).

    Time to get Phase 1B readout depends on how many dose levels, how many patients in each cohort and time interval for follow-up.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.69
Change
0.010(0.60%)
Mkt cap ! $287.1M
Open High Low Value Volume
$1.69 $1.70 $1.65 $89.01K 53.2K

Buyers (Bids)

No. Vol. Price($)
1 2342 $1.69
 

Sellers (Offers)

Price($) Vol. No.
$1.70 5 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.